Matthias Hübenthal

Great opportunity to learn about recent #dermatological #research conducted by #BIOMAP_IMI

14.03.2025 08:09 — 👍 0    🔁 0    💬 0    📌 0

📢 Do you have #eczema or #psoriasis? You are invited to a FREE online meeting to explore the complexities of eczema and psoriasis with leading experts.
🗓️ 25 March 2025, 17:30–19:00 CET / 16:30–18:00 GMT
📍 Online via Zoom
✍️ Register now via this link: sanofi.zoom.us/webinar/regi...

14.03.2025 08:00 — 👍 0    🔁 0    💬 0    📌 1

Illustration: eine Person wirft ein X in eine Mülltonne

Zeit, neue Wege zu gehen: Gemeinsam mit mehr als 60 weiteren Hochschulen und Forschungsinstitutionen verlassen wir heute X – und starten dafür hier! idw-online.de/de/news845520 #eXit #WissXit #ByeByeX #QuitX | ©️: HHU/Paul Schwaderer

10.01.2025 09:22 — 👍 356    🔁 62    💬 15    📌 7

According to the documentation ASJCs are part of the downloaded version of the source list.

26.11.2024 06:07 — 👍 1    🔁 0    💬 0    📌 0

@scopus.bsky.social provides ASJ codes for all its sources at www.scopus.com/sources.uri

25.11.2024 21:03 — 👍 1    🔁 0    💬 1    📌 0

GitHub - huebenthal-cau/mapSeverityScores Contribute to huebenthal-cau/mapSeverityScores development by creating an account on GitHub.

(5/5) And #github for the respective R package.

20.11.2024 08:37 — 👍 0    🔁 0    💬 0    📌 0

Mapping SCORing of Atopic Dermatitis (SCORAD) and objective SCORAD to the Eczema Area and Severity Index to facilitate large-scale meta-analyses of molecular data We used data from 1501 patients to build mathematical models for mapping between common measures of atopic dermatitis severity, including SCORing of Atopic

(4/5) See #brjdermatol for the article.

20.11.2024 08:37 — 👍 0    🔁 0    💬 1    📌 0

(3/5) We used data from 1501 patients to build mathematical models for mapping between common measures of #atopicdermatitis severity, including oSCORAD, SCORAD and EASI. Therewith, we facilitate progress in harmonizing patient data across studies, enabling important comparative analyses at scale.

20.11.2024 08:37 — 👍 0    🔁 0    💬 1    📌 0

(2/5) Our short paper entitled "Mapping oSCORAD and SCORAD to EASI to facilitate large-scale analyses of omics data" published in #brjdermatol might provide a solution.

20.11.2024 08:37 — 👍 0    🔁 0    💬 1    📌 0

(1/5) Do you aim to perform large-scale multi-cohort analyses of disease severity with data derived from #atopicdermatitis patients but struggle with inhomogeneous definitions of the outcome?

20.11.2024 08:37 — 👍 1    🔁 0    💬 1    📌 0